SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT

12 Months Ended

Dec. 31, 2024

Condensed Financial Information Disclosure [Abstract]

SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Parent Company Only)


Schedule I — Condensed Financial Information of Registrant Condensed Statements of Operations (Parent Company Only)
	Years Ended December 31,
	2024		2023		2022
	(in millions)
Revenues

Net investment income	$	94	$	77	$	16
Other revenues	11		5		6

Total revenues	105		82		22
Banking and deposit interest expense	35		35		8
Total net revenues	70		47		14

Expenses

Distribution expenses	61		46		4
Interest and debt expense	144		138		104
General and administrative expense	328		306		265
Total expenses	533		490		373
Pretax loss before equity in earnings of subsidiaries	(463)		(443)		(359)
Income tax provision	182		142		139
Loss before equity in earnings of subsidiaries	(645)		(585)		(498)
Equity in earnings of subsidiaries, net of tax	4,046		3,141		3,647
Net income	3,401		2,556		3,149
Other comprehensive income (loss), net of tax	(142)		780		(1,904)
Total comprehensive income (loss)	$	3,259	$	3,336	$	1,245

See Notes to Condensed Financial Information of Registrant.


Schedule I — Condensed Financial Information of Registrant Condensed Balance Sheets (Parent Company Only)
	December 31,
	2024		2023
	(in millions, except share amounts)
Assets
Cash and cash equivalents	$	844	$	519
Investments	921		841
Loans to subsidiaries	343		489
Due from subsidiaries	273		246
Receivables	26		49
Land, buildings, equipment, and software, net of accumulated depreciation of $779 and $791, respectively	303		265
Investments in subsidiaries	6,910		6,974
Other assets	1,605		1,580
Total assets	$	11,225	$	10,963

Liabilities and Equity
Liabilities:
Accounts payable and accrued expenses	$	1,422	$	1,229
Due to subsidiaries	347		347
Borrowings from subsidiaries	756		580
Long-term debt	2,842		3,398
Other liabilities	630		680
Total liabilities	5,997		6,234

Equity:
Common shares ($0.01 par value; shares authorized, 1,250,000,000; shares issued, 337,729,050 and 336,780,893, respectively)	3		3
Additional paid-in capital	10,141		9,824
Retained earnings	24,713		21,905
Treasury shares, at cost (241,562,357 and 236,607,681 shares, respectively)	(27,721)		(25,237)
Accumulated other comprehensive income (loss), net of tax, including amounts applicable to equity investments in subsidiaries	(1,908)		(1,766)
Total equity	5,228		4,729
Total liabilities and equity	$	11,225	$	10,963

See Notes to Condensed Financial Information of Registrant.


Schedule I — Condensed Financial Information of Registrant Condensed Statements of Cash Flows (Parent Company Only)
	Years Ended December 31,
	2024		2023		2022
	(in millions)
Cash Flows from Operating Activities
Net income	$	3,401	$	2,556	$	3,149
Equity in earnings of subsidiaries	(4,046)		(3,141)		(3,647)
Dividends received from subsidiaries	3,731		3,025		2,512

Other operating activities, primarily with subsidiaries	422		453		226
Net cash provided by (used in) operating activities	3,508		2,893		2,240

Cash Flows from Investing Activities
Available-for-Sale securities:
Proceeds from sales	—		4		—
Maturities, sinking fund payments and calls	55		43		153
Purchases	(128)		(38)		(124)
Proceeds from sales of other investments	—		—		7
Purchase of other investments	—		(10)		(1)

Purchase of land, buildings, equipment and software	(59)		(87)		(70)



Contributions to subsidiaries	(145)		(324)		(743)
Return of capital from subsidiaries	351		—		207
Repayment of loans to subsidiaries	3,406		1,992		1,960
Issuance of loans to subsidiaries	(3,260)		(2,232)		(1,726)

Other, net	(1)		2		—
Net cash provided by (used in) investing activities	219		(650)		(337)

Cash Flows from Financing Activities
Dividends paid to shareholders	(574)		(550)		(534)
Repurchase of common shares	(2,448)		(2,127)		(1,978)

Issuance of long-term debt, net of issuance costs	—		1,335		495
Repayments of long-term debt	(561)		(760)		(510)
Borrowings from subsidiaries	726		1,003		1,210
Repayments of borrowings from subsidiaries	(586)		(951)		(1,034)

Other, net	41		(35)		(18)
Net cash provided by (used in) financing activities	(3,402)		(2,085)		(2,369)
Net increase (decrease) in cash and cash equivalents	325		158		(466)
Cash and cash equivalents at beginning of period	519		361		827
Cash and cash equivalents at end of period	$	844	$	519	$	361

Supplemental Disclosures:
Interest paid on debt	$	148	$	129	$	98
Income taxes paid, net	179		233		91
Non-cash dividends from subsidiaries	—		77		—

See Notes to Condensed Financial Information of Registrant.

Schedule I — Condensed Financial Information of Registrant

Notes to Condensed Financial Information of Registrant

(Parent Company Only)

1. Basis of Presentation

The accompanying Condensed Financial Statements include the accounts of Ameriprise Financial, Inc. (the “Parent Company”) and, on an equity basis, its subsidiaries and affiliates. The Condensed Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles. The financial information of the Parent Company should be read in conjunction with the Consolidated Financial Statements and Notes of Ameriprise Financial, Inc. and its subsidiaries (“Ameriprise Financial”). Parent Company revenues and expenses, other than interest and debt expense, are primarily related to intercompany transactions with subsidiaries and affiliates.

2. Investments

On December 23, 2020, RiverSource Life Insurance Company (“RiverSource Life”) issued a $500 million unsecured 3.5% surplus note due December 31, 2050 to the Parent Company. The surplus note is subordinate in right of payment to the prior payment in full of RiverSource Life’s obligations to policyholders, claimants and beneficiaries and all other creditors. No payment of principal or interest shall be made without the prior approval of the Minnesota Department of Commerce and such payments shall be made only from RiverSource Life’s statutory surplus. Interest payments, which commenced on June 30, 2021, are due semi-annually in arrears on June 30 and December 31. Subject to the preceding conditions, RiverSource Life may prepay all or a portion of the principal at any time. The held-to-maturity investment was $500 million as of both December 31, 2024 and 2023 and is recorded in Investments on the Parent Company’s Condensed Balance Sheets. For the years ended December 31, 2024, 2023 and 2022, interest income was $18 million and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

In June of 2024, the Parent Company invested $69 million in an unrated residual tranche issued by Ameriprise Installment Financing, LLC, a subsidiary of the Parent Company. The residual tranche is collateralized by a portfolio of loans issued to advisors affiliated with Ameriprise Financial Services, LLC (“AFS”), a subsidiary of the Parent Company. As of December 31, 2024, the fair value of the residual tranche was $60 million and is reported in Investments on the Parent Company’s Condensed Balance Sheets. Interest income from the residual tranche was $2 million for the year ending December 31, 2024 and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

In September of 2022, the Parent Company redeemed the outstanding unrated residual tranche issued by Ameriprise Advisor Financing, LLC (“AAF”), a subsidiary of the Parent Company, realizing a $23 million loss, and invested $30 million in a new unrated residual tranche issued by Ameriprise Advisor Financing 2, LLC (“AAF 2”). As of December 31, 2024 and 2023, the fair value of the residual tranche was $56 million and $30 million, respectively, and is reported in Investments on the Parent Company’s Condensed Balance Sheets. Interest income from the residual tranche was $7 million for the years ended December 31, 2024, 2023 and 2022 and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

3. Debt

All of the debt of Ameriprise Financial is borrowings of the Parent Company, except as indicated below.

•As of both December 31, 2024 and 2023, Ameriprise Financial had $201 million of borrowings from the Federal Home Loan Bank of Des Moines, which is primarily collateralized with commercial mortgage backed securities and residential mortgage backed securities.

•As of December 31, 2024 and 2023, Ameriprise Financial debt included nil and $1 million, respectively, of other subsidiary lease obligations.

4. Borrowings from Subsidiaries

The Parent Company has intercompany lending arrangements with its subsidiaries. At the end of each business day, taking into consideration all legal and regulatory requirements associated with its subsidiaries, the Parent Company is entitled to draw on all funds in specified bank accounts. Repayment of all or a portion of the funds is due on demand. As of December 31, 2024 and 2023, the Company had $415 million and $375 million, respectively, available for repayment due on demand. The Parent Company also has revolving credit agreements with its subsidiaries as the borrower aggregating $1.3 billion as of both December 31, 2024 and 2023, of which $340 million and $205 million was outstanding as of December 31, 2024 and 2023, respectively.

5. Guarantees, Commitments and Contingencies

The Parent Company is the guarantor for operating leases of certain subsidiaries. All consolidated legal, regulatory and arbitration proceedings, including class actions of Ameriprise Financial are potential or current obligations of the Parent Company. The Parent Company has committed revolving credit agreements with its subsidiaries as the lender aggregating $363 million as of both December 31, 2024 and 2023, of which $99 million and $246 million was outstanding as of December 31, 2024 and 2023, respectively.

The Parent Company and Ameriprise Certificate Company (“ACC”) entered into a Capital Support Agreement on March 2, 2009, pursuant to which the Parent Company agrees to commit such capital to ACC as is necessary to satisfy applicable minimum capital requirements. Effective April 30, 2014, this agreement was amended to revise the maximum commitment to $50 million. For the years ended December 31, 2024, 2023 and 2022, ACC did not draw upon the Capital Support Agreement and had met all applicable capital requirements.

AFS entered into a Financial Industry Regulatory Authority (“FINRA”) approved subordinated loan agreement with the Parent Company on December 15, 2014 for regulatory net capital purposes. The agreement consists of a $200 million secured demand note. The note is secured by cash and securities equal to the principal value of the note pledged by the Parent Company. As of both December 31, 2024 and 2023, AFS had not made a demand of the principal amount.

Ameriprise Enterprise Investment Services, Inc. (“AEIS”) entered into a FINRA approved subordinated loan agreement with the Parent Company on January 25, 2017 for regulatory net capital purposes. Under this agreement, AEIS borrowed $60 million from the Parent Company with an initial term of five years to be repaid no later than January 25, 2022. Both companies have the option to renew the agreement in one year-increments in perpetuity. The agreement was renewed in January 2022 and each year thereafter, extending the current maturity date to January 25, 2026.

6. Subsequent Events

The Parent Company made two $30 million cash contributions to Ameriprise Advisor Capital, LLC. The first occured on January 6, 2025 and the second occurred on January 27, 2025.